Open Access

Table 1

Baseline characteristics of real-world patients. Demographics of 18 real-world patients from the TheraBionic registry. All patients had a diagnosis of advanced HCC and received treatment with HCC-specific frequencies.

Age Gender Race Previous treatment BCLC stage Extra hepatic mets Child-Pugh α-Fetoprotein ≥ 400 ng/mL ECOG PS POD prior to treatment
58 M Caucasian Yes C Yes A5 Yes 1 Yes
79 M Caucasian Yes C Yes A6 Yes 1 Yes
86 M Caucasian No C No A5 No 2 No
68 F Caucasian Yes C Yes A6 Yes 2 Yes
36 M Caucasian Yes C Yes B8 No 2 Yes
84 M Caucasian Yes C No A6 No 3 Yes
74 F Caucasian Yes C Yes A6 Yes 1 No
79 M Caucasian Yes C Yes B9 No 2 Yes
63 M Arab / Saudi Arabia Yes C Yes C10 Yes 3 Yes
46 M Black Yes C Yes B9 Yes 1 Yes
76 M Caucasian Yes C Yes B7 Yes 3 Yes
70 F Caucasian Yes C No A6 No 1 Yes
46 M Caucasian Yes C Yes A5 No 1 Yes
63 M Caucasian Yes C No A5 Yes 2 Yes
74 M Caucasian Yes C Yes A6 Yes 2 Yes
75 M Caucasian Yes C Yes A6 No 2 Yes
58 M Caucasian Yes C Yes A6 No 2 Yes
72 M Hispanic Yes D No C11 Yes 2 Yes

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.